Clinical trial
Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients…
NCT00145353 · Odense University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00145353 |
|---|---|
| Title | Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose |
| Official title | Is Insulin NovoRapid Better Than Actrapid for Treating Type 1 Diabetic Patients When Simultaneously, Daily Adjusting the Insulin Dose? |
| Lead sponsor | Odense University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin NovoRapid versus Actrapid |
| Enrollment | 16 |
| Start date | Nov 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Sep 5, 2005 |
| Last update posted | Oct 11, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: